Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Pedal Pump Device for Lower Extremity Edema in Hospitalized Patients

Official title: Pedal Pump Clinical Trial on Edema V1

Run by Hillcrest · NCT07760363 · Data updated 2026-11-12

This study tests a foot-pump device to see if it is tolerable and can help reduce swelling in the legs of hospitalized patients with edema.

More Kidney Disease trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorHillcrest
Industry-sponsored
Locations1 site (Tulsa, Oklahoma)
StatusRecruiting
StartedAugust 6, 2026
Main results expectedSeptember 30, 2026
Study endsOctober 31, 2026
Registry record updatedAugust 12, 2026
Trial IDNCT07760363 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are medically stable adults with mild to moderate bilateral lower extremity edema due to heart, vein, or kidney conditions, able to lie in Fowler position for 10 minutes and provide informed consent.

Probably not a fit

Patients with active DVT, lymphedema, lipedema, pressure ulcers, or contraindicating bed equipment may not benefit from this device.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This feasibility study evaluates a pedal pump device used for 10 minutes to treat bilateral lower extremity edema in hospitalized patients. Patients are positioned in Fowler's position and receive the device treatment on both feet, with assessments before, after, and at follow-up to gauge tolerability and edema changes. The trial includes a sham pedal pump arm for comparison and examines whether the device can be tolerated in a hospital setting and whether it lowers leg fluid volume. The study is conducted at Hillcrest Medical Center in Tulsa, Oklahoma, led by David McVay, with eligibility focused on clinically edema due to CHF, CVI, kidney disease, or fluid overload.

Why it matters

Potential benefit: If successful, the pedal pump could provide a noninvasive option to reduce leg edema and improve comfort in hospitalized patients.

How similar studies have gone: Prior work with manual pedal pumping suggested benefits in edema and lymphatic flow, but this device-enabled approach is novel and feasibility-focused in a hospital setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Bilateral lower extremity edema of at least mild severity judged by the treating clinician to be due to CHF, chronic venous insufficiency, kidney disease, or other etiologies of fluid overload conditions.
* Medically stable
* Able to remain in Fowler position for 10 minutes
* Patients in the ER, observation, or admitted to the hospital for any period of time; outpatients (specifically CHF clinic patients)
* Patients must give informed consent to participate. The patient must be able to read the consent form (in English or Spanish) or give consent after the form is translated for the patient.

Exclusion Criteria:

* Patients using a hospital bed which has the scale on the foot board
* Lymphedema (interstitial protein-built fluid)
* Lipedema (fat distribution)
* Pressure ulcers
* Active DVT (i.e. Patients who have signs of acute unilateral swelling must have a documented negative lower extremity venous duplex ultrasound within the current admission before they will be included in the trial.)
* Symptomatic peripheral vascular disease
* Wounds or infections in the feet, legs, buttocks, or back
* Weeping lymphedema or bullous cellulitis
* Uncontrolled hypertension (BP\>180/110) in the recent 2 hours
* Uncontrolled hypotension (BP \<80/45) in the recent 2 hours
* Heart rate greater than 110 or less than 45 in the recent 2 hours
* Leg or back surgery in previous 30 days
* Known pregnancy
* Severe osteoporosis/fracture risk

Where it's running

  • Hillcrest Medical Center
    Tulsa, Oklahoma, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.